Loading viewer...
investor_presentation
Format: PDF investor_presentation
Okta's Q2 FY25 investor presentation delivered on August 28, 2024, covering company overview, financial results, and forward guidance. The presentation details second quarter fiscal 2025 performance, Q3 and full-year financial outlook, and business strategy. Includes safe harbor disclosures and risk factors relevant to the identity and access management software provider.
IOL Chemicals and Pharmaceuticals Q4 FY23 Investor Presentation 2023
investor_presentationinvestor_presentation
31 Pages
IOL Chemicals and Pharmaceuticals Limited